Inflammatory bowel disease: Sorting out the treatment options
Jason M. Wolf, MD
Department of Gastroenterology, The Cleveland Clinic
Bret A. Lashner, MD
Director, Center for Inflammatory Bowel Disease, Department of Gastroenterology, The Cleveland Clinic
Address: Bret A. Lashner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail firstname.lastname@example.org
ABSTRACTAn increasing array of treatments such as immunosuppressive drugs and tumor necrosis factor inhibitors can offer patients with ulcerative colitis and Crohn disease improved relief from symptoms with fewer adverse effects. Several additional drugs have shown promise, including nicotine, antimicrobials, and heparin.